(() => { const ua = navigator.userAgent; const noMobile = !(/(iPhone|iPad|iPod|iOS)/i.test(ua) || /Windows\sPhone/i.test(ua) || /(Android)/i.test(ua)); setTimeout(() => { noMobile && document.title === '' && (document.title = '微信公眾平臺'); }, 1000); window.addEventListener('securitypolicyviolation', (e) => { if (e.effectiveDirective === 'base-uri') { (new Image()).src = location.protocol + '//mp.weixin.qq.com/mp/jsmonitor?idkey=523105_1_1&r=' + Math.random(); } const reportData = { violatedDirective: e.effectiveDirective, blockedURI: e.blockedURI, sourceFile: e.sourceFile, lineNumber: e.lineNumber, columnNumber: e.columnNumber, disposition: e.disposition, referrer: e.referrer, sample: e.sample, originalPolicy: e.originalPolicy }; let str = ''; const keys = Object.keys(reportData); for (let i = 0; i < keys.length; i++) { const key = keys[i]; str += key + ': ' + reportData[key] + ' || '; } str += 'location: ' + location.href; window.WX_BJ_REPORT && window.WX_BJ_REPORT.BadJs && window.WX_BJ_REPORT.BadJs.report( e.effectiveDirective, str, { mid: 'mmbizwap:csp_report', view: 'wap_business' } ); }); })();
6月28日,海南省腫瘤醫(yī)院引進一款針對HER2陽性晚期乳腺癌的創(chuàng)新藥——德曲妥珠單抗(優(yōu)赫得)。該院乳腺腫瘤中心副主任劉俠開出了該藥在國內(nèi)上市后的首張臨床治療處方。
來源:新海南客戶端、南海網(wǎng)、南國都市報
記者:王洪旭
編輯:陳國興
內(nèi)容審核:肖婧菁
值班主任:袁蘭
大家都在看